Non-viral genetic medicines
The medicines are designed for local delivery to disease sites, starting with non-muscle invasive bladder cancer and expanding beyond.
Source: LinkedIn company description · Retrieved October 13, 2026
enGene is a clinical-stage biotechnology company developing non-viral genetic medicines for local delivery to disease sites.
Founded in Canada, enGene is headquartered in Boston, United States. enGene has sites in the United States, Canada, Europe and the Asia-Pacific region.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The LEGEND clinical trial is enrolling select patients with non-muscle invasive bladder cancer.
The medicines are designed for local delivery to disease sites, starting with non-muscle invasive bladder cancer and expanding beyond.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 2, 2026, September 14, 2026, September 15, 2026, September 16, 2026, September 18, 2026, September 19, 2026, September 21, 2026 and September 27, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.